In this article, we describe the synthesis of a small library of short peptoids composed of four glycine residues and acylated with a fatty acid that showed a remarkable in vitro activity against two fungal plant pathogens. Their straightforward synthesis implied two consecutive Ugi reactions and can be efficiently extended to the construction of highly diverse libraries.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11030-011-9334-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Robust Multifunctional Ultrathin 2 Nanometer Organic Nanofibers.
ACS Nano
August 2024
Shanghai Key Laboratory of Advanced Polymeric Materials, Frontiers Science Center for Materiobiology and Dynamic Chemistry, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai 200237, China.
Ultrathin organic nanofibers (UTONFs) represent an emerging class of nanomaterials as they carry a set of favorable attributes, including ultrahigh specific surface area, lightweight, and mechanical flexibility, over inorganic counterparts, for use in biomedicine and nanotechnology. However, precise synthesis of uniform UTONFs (diameter ≤ 2 nm) with tailored functionalities remained challenging. Herein, we report robust multifunctional UTONFs using hydrophobic interaction-driven self-assembly of amphiphilic alternating peptoids containing hydrophobic photoresponsive azobenzene and hydrophilic hydroxyl moieties periodically arranged along the peptoid backbone.
View Article and Find Full Text PDFPeptide Boronic Acids by Late-Stage Hydroboration on the Solid Phase.
Adv Sci (Weinh)
July 2024
Institute of Organic Chemistry, Heidelberg University, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany.
Organoboron compounds have a wide range of applications in numerous research fields, and methods to incorporate them in biomolecules are much sought after. Here, on-resin chemical syntheses of aliphatic and vinylogous peptide boronic acids are presented by transition metal-catalyzed late-stage hydroboration of alkene and alkyne groups in peptides and peptoids, for example on allyl- and propargylglycine residues, using readily available chemicals. These methods yield peptide boronic acids with much shorter linkers than previously reported on-resin methods.
View Article and Find Full Text PDFAssembly of short amphiphilic peptoids into nanohelices with controllable supramolecular chirality.
Nat Commun
April 2024
Department of Chemical Engineering, University of Washington, Seattle, WA, 98195, USA.
A long-standing challenge in bioinspired materials is to design and synthesize synthetic materials that mimic the sophisticated structures and functions of natural biomaterials, such as helical protein assemblies that are important in biological systems. Herein, we report the formation of a series of nanohelices from a type of well-developed protein-mimetics called peptoids. We demonstrate that nanohelix structures and supramolecular chirality can be well-controlled through the side-chain chemistry.
View Article and Find Full Text PDFShort Peptoid Evolved from the Key Hydrophobic Stretch of Amyloid-β42 Peptide Serves as a Potent Therapeutic Lead of Alzheimer's Disease.
ACS Chem Neurosci
January 2023
Department of Bioscience & Bioengineering, Indian Institute of Technology Jodhpur, NH 65, Surpura Bypass Road, Karwar, Jodhpur, Rajasthan 342037, India.
Amyloid-β 42(Aβ42), an enzymatically cleaved (1-42 amino acid long) toxic peptide remnant, has long been reported to play the key role in Alzheimer's disease (AD). Aβ42 also plays the key role in the onset of other AD-related factors including hyperphosphorylation of tau protein that forms intracellular neurofibrillary tangles, imbalances in the function of the neurotransmitter acetylcholine, and even generation of reactive oxygen species (ROS), disrupting the cytoskeleton and homeostasis of the cell. To address these issues, researchers have tried to construct several strategies to target multiple aspects of the disease but failed to produce any clinically successful therapeutic molecules.
View Article and Find Full Text PDFPotential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis.
Curr Neuropharmacol
October 2023
School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, Monza, 20900, Italy.
Article Synopsis
- Amyotrophic lateral sclerosis (ALS) is caused by the death of neurons and involves a mix of genetic, molecular, and environmental factors; currently, only two drugs are approved for treatment.
- Ghrelin, a hormone linked to growth hormone secretion, shows potential neuroprotective effects that may be useful in treating ALS, although its natural form is unstable and not prevalent in circulation.
- Synthetic compounds known as growth hormone secretagogues (GHS) can mimic ghrelin's effects and have shown promise in providing neuroprotection, with some being safely evaluated for use in humans, indicating potential as therapies for ALS.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!